Prodromal Alzheimer's Disease: Constitutive Upregulation of Neuroglobin Prevents the Initiation of Alzheimer's Pathology.

Alzheimer’s disease Amyloid-beta peptide dendritic complexity neuroglobin resilience

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2020
Historique:
received: 15 05 2020
accepted: 28 08 2020
entrez: 21 12 2020
pubmed: 22 12 2020
medline: 22 12 2020
Statut: epublish

Résumé

In humans, a considerable number of the autopsy samples of cognitively normal individuals aged between 57 and 102 years have revealed the presence of amyloid plaques, one of the typical signs of AD, indicating that many of us use mechanisms that defend ourselves from the toxic consequences of Aß. The human APP NL/F (hAPP NL/F) knockin mouse appears as the ideal mouse model to identify these mechanisms, since they have high Aß42 levels at an early age and moderate signs of disease when old. Here we show that in these mice, the brain levels of the hemoprotein Neuroglobin (Ngb) increase with age, in parallel with the increase in Aß42.

Identifiants

pubmed: 33343276
doi: 10.3389/fnins.2020.562581
pmc: PMC7744294
doi:

Types de publication

Journal Article

Langues

eng

Pagination

562581

Informations de copyright

Copyright © 2020 de Vidania, Palomares-Perez, Frank-García, Saito, Saido, Draffin, Szaruga, Chávez-Gutierrez, Calero, Medina, Guix and Dotti.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Free Radic Res. 2011 Jun;45(6):681-91
pubmed: 21417547
Arch Neurol. 1999 Jun;56(6):713-8
pubmed: 10369312
J Alzheimers Dis. 2018;62(3):1305-1317
pubmed: 29562535
J Biol Chem. 2012 Aug 31;287(36):30128-38
pubmed: 22787149
Mol Neurodegener. 2015 Nov 05;10:60
pubmed: 26541821
J Neurosci. 2000 Sep 1;20(17):6452-8
pubmed: 10964951
Nat Neurosci. 2014 May;17(5):661-3
pubmed: 24728269
Neurology. 2006 Jun 27;66(12):1837-44
pubmed: 16801647
Biochim Biophys Acta. 2016 Jan;1862(1):105-12
pubmed: 26542217
FEBS Lett. 2011 Feb 18;585(4):651-6
pubmed: 21256848
Neurobiol Learn Mem. 2016 Nov;135:73-82
pubmed: 27377630
J Mol Biol. 2006 Dec 15;364(5):853-62
pubmed: 17046788
Ann Neurol. 1999 Mar;45(3):358-68
pubmed: 10072051
Arch Neurol. 2008 Nov;65(11):1509-17
pubmed: 19001171
Neurobiol Aging. 2008 Dec;29(12):1815-22
pubmed: 17560688
Brain Res. 2008 Jan 23;1190:159-66
pubmed: 18083144
Neurochem Res. 2004 Jun;29(6):1287-97
pubmed: 15176485
PLoS One. 2011;6(12):e28160
pubmed: 22164238
Sci Rep. 2016 May 13;6:25841
pubmed: 27173984
PLoS One. 2012;7(4):e34462
pubmed: 22496809
Brain Res. 1991 Feb 1;540(1-2):83-95
pubmed: 2054635
J Neurol Sci. 2017 Apr 15;375:52-57
pubmed: 28320188
Biomolecules. 2019 Nov 13;9(11):
pubmed: 31766231
Front Aging Neurosci. 2015 Sep 30;7:181
pubmed: 26483681
BMC Neurosci. 2007 May 02;8:29
pubmed: 17475015
Nature. 2000 Sep 28;407(6803):520-3
pubmed: 11029004
Biochem Biophys Res Commun. 2000 Jul 14;273(3):1003-7
pubmed: 10891362
J Neurochem. 2017 Jan;140(1):151-169
pubmed: 27787886
PLoS One. 2009;4(4):e5088
pubmed: 19352431
Nature. 2002 Apr 4;416(6880):535-9
pubmed: 11932745
Biochim Biophys Acta. 2006 Jun;1762(6):575-86
pubmed: 16644188
Front Mol Neurosci. 2019 Feb 22;12:24
pubmed: 30853886
J Neurol Neurosurg Psychiatry. 1988 Aug;51(8):1088-90
pubmed: 3216211
Apoptosis. 2010 Apr;15(4):401-11
pubmed: 20091232
Sci Transl Med. 2016 Dec 7;8(368):368ra173
pubmed: 27928027
EMBO Mol Med. 2012 Jul;4(7):660-73
pubmed: 22488900
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19114-9
pubmed: 18025470
J Alzheimers Dis. 2010;20 Suppl 2:S609-31
pubmed: 20463406
Brain Res. 1991 Feb 1;540(1-2):63-82
pubmed: 2054634
Biochim Biophys Acta. 2007 Aug;1768(8):1976-90
pubmed: 17433250
Nat Med. 2019 Nov;25(11):1680-1683
pubmed: 31686034
Ann Neurol. 1998 May;43(5):673-6
pubmed: 9585365
Immun Ageing. 2005 Jul 16;2:11
pubmed: 16022734
J Cereb Blood Flow Metab. 2010 Nov;30(11):1874-82
pubmed: 20571522
iScience. 2020 Apr 24;23(4):101005
pubmed: 32272441
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3591-6
pubmed: 17360687
Nat Neurosci. 2004 Nov;7(11):1181-3
pubmed: 15475950
Front Physiol. 2012 Dec 20;3:464
pubmed: 23267328
J Neurochem. 2019 Nov;151(4):459-487
pubmed: 30216447
Exp Transl Stroke Med. 2012 Aug 20;4(1):15
pubmed: 22901501
Science. 2004 Apr 16;304(5669):448-52
pubmed: 15087549
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Ann N Y Acad Sci. 2007 Feb;1097:30-9
pubmed: 17413007
Sci Rep. 2014 May 15;4:4983
pubmed: 24828380
Arch Clin Neuropsychol. 2009 Jun;24(4):395-411
pubmed: 19648583
J Biol Chem. 2011 May 20;286(20):18277-89
pubmed: 21296891
Neurobiol Aging. 2010 Nov;31(11):1835-42
pubmed: 19010568
Biophys J. 2008 Oct;95(7):3447-56
pubmed: 18599641
Alzheimers Dement. 2015 Jun;11(6):600-7.e1
pubmed: 25130657
J Neurochem. 2012 Jan;120(1):157-64
pubmed: 21496024
Neuron. 2009 Jun 25;62(6):788-801
pubmed: 19555648
Biochem Biophys Res Commun. 2004 Feb 6;314(2):555-60
pubmed: 14733943
Neurobiol Aging. 1996 May-Jun;17(3):365-71
pubmed: 8725897
J Mol Neurosci. 2016 Jan;58(1):28-38
pubmed: 26346601
Curr Alzheimer Res. 2008 Dec;5(6):548-54
pubmed: 19075581
Prog Neurobiol. 2020 Aug;191:101818
pubmed: 32380223
J Neurosci. 2010 Feb 17;30(7):2636-49
pubmed: 20164348
Brain. 2016 Mar;139(Pt 3):922-36
pubmed: 26813969

Auteurs

Silvia de Vidania (S)

Molecular Neuropathology, Physiological and Pathological Processes, Centro de Biología Molecular Severo Ochoa, CSIC/UAM, Madrid, Spain.

Irene Palomares-Perez (I)

Molecular Neuropathology, Physiological and Pathological Processes, Centro de Biología Molecular Severo Ochoa, CSIC/UAM, Madrid, Spain.

Ana Frank-García (A)

Department of Neurology, Instituto de Salud Carlos III (ISCIII), Division Neurodegenerative Disease, University Hospital La Paz, Madrid, Spain.

Takashi Saito (T)

Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Wako-shi, Japan.

Takaomi C Saido (TC)

Department of Neurocognitive Science, Nagoya City University Graduate School of Medical Science, Nagoya, Japan.

Jonathan Draffin (J)

Molecular Neuropathology, Physiological and Pathological Processes, Centro de Biología Molecular Severo Ochoa, CSIC/UAM, Madrid, Spain.

María Szaruga (M)

KU Leuven Department for Neurosciences, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.

Lucía Chávez-Gutierrez (L)

KU Leuven Department for Neurosciences, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.

Miguel Calero (M)

CIBERNED, Queen Sofia Foundation Alzheimer Center, CIEN Foundation, Instituto de Salud Carlos III, Madrid, Spain.

Miguel Medina (M)

CIBERNED, Queen Sofia Foundation Alzheimer Center, CIEN Foundation, Instituto de Salud Carlos III, Madrid, Spain.

Francesc X Guix (FX)

Molecular Neuropathology, Physiological and Pathological Processes, Centro de Biología Molecular Severo Ochoa, CSIC/UAM, Madrid, Spain.

Carlos G Dotti (CG)

Molecular Neuropathology, Physiological and Pathological Processes, Centro de Biología Molecular Severo Ochoa, CSIC/UAM, Madrid, Spain.

Classifications MeSH